台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    60.0
  • 漲跌
    ▲0.2
  • 漲幅
    +0.33%
  • 成交量
    11
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智基 (6294)籌碼相關-玉山-嘉義 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

玉山-嘉義 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/17058.2000.0058.800910.03%
2025/01/1600.000.559.0059.00-0.591-0.55%
2025/01/15159.0000.0059.001911.09%
2025/01/06060.5000.0060.600900.00%
2025/01/030.160.8000.0060.600.1900.11%
2025/01/020.160.7000.0060.700.1900.11%
2024/12/090.166.6000.0066.400.1940.07%
2024/11/27164.7000.0064.701991.01%
2024/11/220.264.0000.0063.400.2960.21%
2024/11/210.563.3800.0063.300.5940.53%
2024/11/2000.00265.2064.40-291-2.19%
2024/11/180.172.8000.0070.700.1900.11%
2024/11/15072.10171.4072.60-1101-0.97%
2024/11/142.274.7700.0069.702.21022.14%
2024/11/134.277.4700.0077.404.2974.29%
2024/11/126.286.02986.0086.00-2.890-3.10%
2024/11/0800.00696.6096.60-6103-5.80%
2024/10/300.297.0000.0096.400.21340.15%
2024/10/280.296.8000.0096.400.21350.11%
2024/10/250.297.0000.0096.500.21360.15%
2024/10/211.196.8500.0096.701.11370.80%
2024/10/16197.10296.9096.90-1137-0.73%
2024/10/11197.4000.0097.4011370.72%
2024/10/0900.00397.1797.40-3138-2.17%
2024/09/2700.00197.6097.70-1138-0.72%
2024/09/185.297.0000.0096.205.21393.73%
2024/09/13197.0000.0096.8011400.71%
2024/09/12197.3000.0096.8011400.71%
2024/09/11096.5000.0096.1001390.01%
2024/09/10198.1000.0096.5011390.71%
2024/09/09498.60197.9098.1031372.18%
2024/09/050.2100.5000.0099.700.21400.11%
2024/09/04399.0700.0099.5031412.12%
2024/09/031100.5000.00100.5011390.72%
2024/09/022100.751100.50100.5011390.72%
2024/08/301.1100.6200.00101.001.11390.82%
2024/08/290.2101.000.1101.00101.000.11380.07%
2024/08/282100.7500.00100.5021381.44%
2024/08/271101.0000.00101.0011370.73%
2024/08/262101.5000.00101.0021371.46%
2024/08/231101.5000.00102.0011360.73%
2024/08/221102.501102.50102.0001360.00%
2024/08/201105.5000.00104.5011330.75%
2024/08/192106.2500.00106.0021301.54%
2024/08/1600.004105.38105.00-4118-3.37%
2024/08/151103.001105.00102.5001140.00%
2024/08/1400.002103.25104.50-2112-1.77%
2024/08/132102.001102.00101.5011090.92%
2024/08/121104.001103.00102.500990.00%
2024/08/09398.17399.03100.500930.00%
2024/08/083105.001108.00105.002952.09%
2024/08/06198.40298.65100.00-190-1.11%
2024/08/05198.30198.0098.800890.00%
2024/08/021100.5000.00100.501881.13%
2024/07/181101.5000.00101.501901.10%
2024/07/151101.5000.00101.501921.08%
2024/06/2700.001101.00100.50-1136-0.73%
2024/06/2400.000.5100.50100.50-0.5139-0.36%
2024/06/190101.0000.00101.0001430.02%
2024/06/1800.000.5100.50101.00-0.5145-0.34%
2024/06/170.2101.5000.00101.000.21460.14%
2024/06/131100.5000.00100.5011520.66%
2024/06/121101.0000.00101.0011550.64%
2024/06/0400.000.1102.50103.00-0.1158-0.06%
2024/06/033102.5000.00102.5031591.89%
2024/05/290.2103.0000.00102.500.21590.09%
2024/05/270103.5000.00102.5001580.01%
2024/05/230.2103.0000.00102.500.21570.10%
2024/05/210103.001102.50102.00-1155-0.63%
2024/05/203.2104.021.5103.17103.501.71541.07%
2024/05/170.1106.0000.00105.500.11520.04%
2024/05/1600.001107.00107.00-1150-0.67%
2024/05/150.2103.5000.00104.000.21480.11%
2024/05/141.7101.534.498.27102.00-2.7144-1.87%
2024/05/131107.002.1107.00107.00-1.1127-0.89%
2024/05/092118.5000.00118.5021191.67%
2024/04/1600.000.2114.94114.00-0.2111-0.21%
2024/04/1200.000.1117.99118.00-0.1104-0.09%
2024/04/111119.002.2119.09119.50-1.2101-1.18%
2024/04/104.2127.001127.50127.003.2953.38%
2024/04/090.3124.0000.00124.000.3770.39%
2024/03/290122.0000.00122.000680.00%
2024/03/271121.002.7121.65122.00-1.766-2.61%
2024/03/261123.0000.00123.001631.57%
2024/03/250.7124.3400.00124.000.7621.16%
2024/03/2100.007121.71121.50-758-11.96%
2024/03/185123.2000.00124.005519.77%
2024/03/151121.501121.00121.50047-0.01%
2024/03/140119.5000.00119.000430.01%
2024/03/1200.001117.00117.00-138-2.57%
2024/03/1100.003114.50114.50-336-8.30%
2024/03/061113.5000.00113.501342.91%
2024/03/057113.0000.00113.5073320.73%
2024/01/311111.0000.00111.501313.19%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音